Literature DB >> 12791842

Genetic variability among Group A and B respiratory syncytial virus isolates from a large referral hospital in New Delhi, India.

Maitreyi S Rajala1, Wayne M Sullender, A K Prasad, Lalit Dar, Shobha Broor.   

Abstract

Respiratory syncytial virus (RSV) is an important childhood pathogen of acute lower respiratory infections in developed and developing countries. The molecular epidemiology of RSV in India is largely unknown. The present study was undertaken to standardize and evaluate reverse transcription-PCR (RT-PCR) for the rapid and simultaneous detection of RSV groups A and B in clinical samples and to study intragroup genetic variability. RT-PCR was evaluated by comparing the results of seminested RT-PCR with centrifugation-enhanced cultures on 200 nasopharyngeal aspirates from children with acute lower respiratory infections. RSV was isolated in 34 nasopharyngeal aspirates by centrifugation-enhanced cultures and identified in 45 samples by RT-PCR. In 15 samples RSV was identified by seminested RT-PCR alone and in four by centrifugation-enhanced cultures alone. Of the 45 samples positive for RSV by nested PCR, 15 belonged to group A, 29 to group B, and one sample suggested a mixed infection. Group B RSV predominated in both years of the 2-year study. Genetic variability within RSV groups was studied by restriction fragment analysis of 35 PCR products. Among both group A and group B RSV, two different composite patterns were observed. Thus, RSV was found to be a major pathogen of acute lower respiratory tract infections in India, as it was detected in 24.5% of children by RT-PCR. RT-PCR provides a sensitive method for detection and typing of RSV group A and B viruses in clinical samples as well as a means to study intragroup variations. However, a higher sensitivity of detection of RSV in clinical samples can be obtained by its combination with additional techniques, such as virus cultivation.

Entities:  

Mesh:

Year:  2003        PMID: 12791842      PMCID: PMC156520          DOI: 10.1128/JCM.41.6.2311-2316.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Comparison of tube cultures of Madin Darby canine kidney cells with shell-vial cultures after low-speed centrifugation for influenza virus isolation.

Authors:  A E Ling; S Doraisingham
Journal:  Pathology       Date:  1988-10       Impact factor: 5.306

2.  Rapid detection of respiratory viruses by centrifugation enhanced cultures from children with acute lower respiratory tract infections.

Authors:  R S Maitreyi; S Broor; S K Kabra; M Ghosh; P Seth; L Dar; A K Prasad
Journal:  J Clin Virol       Date:  2000-02       Impact factor: 3.168

Review 3.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness.

Authors:  Ann R Falsey; Maria A Formica; Edward E Walsh
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Epidemiology of acute lower respiratory disease in children.

Authors:  P Glezen; F W Denny
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

6.  Genetic variability among group A and B respiratory syncytial viruses in Mozambique: identification of a new cluster of group B isolates.

Authors:  Anna Roca; Mari-Paz Loscertales; Llorenç Quintó; Pilar Pérez-Breña; Neide Vaz; Pedro-Luis Alonso; Juan-Carlos Saiz
Journal:  J Gen Virol       Date:  2001-01       Impact factor: 3.891

7.  Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: Comparison of viruses and genotypes responsible for different disease manifestations.

Authors:  M Venter; M Collinson; B D Schoub
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

8.  Analysis of respiratory syncytial virus genetic variability with amplified cDNAs.

Authors:  W M Sullender; L Sun; L J Anderson
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

9.  Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by reverse transcription and polymerase chain reaction amplification.

Authors:  A W Paton; J C Paton; A J Lawrence; P N Goldwater; R J Harris
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

10.  Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia.

Authors:  Leontine J R van Elden; Marian G J van Kraaij; Monique Nijhuis; Karin A W Hendriksen; Ad W Dekker; Maja Rozenberg-Arska; Anton M van Loon
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

View more
  4 in total

1.  Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India.

Authors:  Shama Parveen; Wayne M Sullender; Karen Fowler; Elliot J Lefkowitz; Suresh Kumar Kapoor; Shobha Broor
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

2.  Genetic variability and molecular epidemiology of respiratory syncytial virus subgroup a strains in Japan determined by heteroduplex mobility assay.

Authors:  Yuki Kuroiwa; Kazushige Nagai; Lisa Okita; Hiroyuki Tsutsumi
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

3.  Respiratory syncytial virus genotypes circulating in urban Ghana: February to November 2006.

Authors:  Evangeline Obodai; Richard Asmah; Isaac Boamah; Bamenla Goka; John Kofi Odoom; Theophilus Adiku
Journal:  Pan Afr Med J       Date:  2014-10-06

4.  A prospective three-year cohort study of the epidemiology and virology of acute respiratory infections of children in rural India.

Authors:  Shobha Broor; Shama Parveen; Preeti Bharaj; Velisetty S Prasad; Kavalu N Srinivasulu; Krishna M Sumanth; Suresh Kumar Kapoor; Karen Fowler; Wayne M Sullender
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.